BioSpace News Archive

Business

Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release for March 30, 2023

Surgalign Holdings, Inc. today announced its plans to release financial results for its fourth quarter and full year 2022 after the close of trading on March 30, 2023.

March 21, 2023
·
4 min read
Business

Cormedix Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide a Corporate Update on March 30, 2023

CorMedix Inc. today announced that it will report its financial results for the fourth quarter and year ended December 31, 2022, before the market opens on Thursday, March 30, 2023, and will host a corporate update conference call at 8:30am Eastern Time.

March 21, 2023
·
2 min read
U.S. FDA Grants GrayMatters Health 510(k) Clearance to Market Prism for PTSD

GrayMatters Health (GMH) announced today that it has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its flagship product, Prism for PTSD, the first non-invasive, self-neuromodulation adjunct digital therapy for post-traumatic stress disorder (PTSD).

March 21, 2023
·
4 min read
FDA

ICHNOS SCIENCES RECEIVES ORPHAN DRUG DESIGNATION FOR FIRST-IN-CLASS BISPECIFIC (CD38 x CD47) ANTIBODY INNATE CELL MODULATOR, ISB 1442

Ichnos Sciences Inc. today announced the company has been granted orphan drug designation (ODD) by the U.S. Food and Drug Administration (FDA) for its first-in-class biparatopic 2+1 BEAT® bispecific antibody targeting CD38 and CD47 for the treatment of relapsed/refractory multiple myeloma (MM).

March 21, 2023
·
3 min read
Business

Jaguar Health to Hold Investor Webcast Monday, March 27th at 8:30 AM EDT Regarding Q4 2022 Financials & Corporate Updates

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Monday, March 27, 2023 at 8:30 a.m. Eastern Daylight Time to review fourth-quarter 2022 financials and provide corporate updates.

March 21, 2023
·
2 min read
Biotech Bay

MyClearStep, Powered by Shapa a Health-tech Company, has Announced an Exciting New Partnership With Top-Tier R1 Research Universities to Conduct Extensive Clinical Trials on Eating Disorders

Health-tech company MyClearStep, powered by Shapa, has announced an exciting new partnership with top-tier R1 research universities to conduct extensive clinical trials on eating disorders.

March 21, 2023
·
2 min read